Sepsis & infection

The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients

Crit CarePublished Retrospective cohort study

Authors' conclusion

Heterogeneous reporting of NE doses significantly affects mortality prediction in septic shock.

Study context

Population
Septic shock patients in the MIMIC-IV database
Participants
4,086 patients
Exposure
Norepinephrine (NE) dose reported as salt formulations (bitartrate, tartrate) vs base molecule for 28-day mortality prediction
Outcome
Prediction of 28-day mortality by NE dose at common severity dose cut-offs
Follow-up
28 days
Methodological detailsMIMIC-IV database
  • MIMIC-IV database

Main finding

As reported in the abstract

28-day mortality prediction by NE dose formulation

Lower ORs

65 %

95% CI 79–43

Bitartrate

Lower ORs

67 %

95% CI 80–47

Tartrate

Observational data: associations, not effects.

Further findings

%

OutcomeTartrateBase molecule
Predicted mortality at 1 μg/kg/min threshold54 (95% CI 52–56)83 (95% CI 80–87)

Cohort characteristics and observed outcome

Median age, years
68 [57-78]
Admission SOFA score
7 [6-10]
Lactate at diagnosis, mmol/L
3.2 [2.4-5.1]
Median peak NE dose at day 1, μg/kg/min
0.24 [0.12-0.42]
28-day mortality
39.3%

Original publication

The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients. Crit Care. Published 3 July 2024. doi:10.1186/s13054-024-05011-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.